Adaptive Biotechnologies vs Ferring Pharmaceuticals

Adaptive Biotechnologies vs Ferring Pharmaceuticals, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Ferring Pharmaceuticals on 36/100.

Adaptive Biotechnologies logo
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.
Try Adaptive Biotechnologies
Ferring Pharmaceuticals logo
Ferring PharmaceuticalsA global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.
Try Ferring Pharmaceuticals

Where each one leads

Adaptive Biotechnologies

  • our overall score: 69/100 against 36/100
  • agent readiness: 39/100 against 25/100

Ferring Pharmaceuticals

  • domain rating: 71/100 against 62/100
  • funding raised: $570M against $300M

At a glance

MeasureAdaptive BiotechnologiesFerring Pharmaceuticals
What it isLeveraging the adaptive immune system to diagnose and treat disease.A global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.
CategoryBiotech, HealthTech, Genomics, Drug DiscoveryBiotech, MedTech, HealthTech, Drug Discovery
Sells toBusiness modelB2BB2B | B2C | B2B2C | B2G
OfferingSoftware | services | platformSoftware | hardware | services | marketplace | platform
Founded20091950
HeadquartersSeattle, United StatesSaint-Prex, Switzerland
StatusActiveActive

Size, funding and growth

MeasureAdaptive BiotechnologiesFerring Pharmaceuticals
Total funding$300M$570M
Latest roundSeries DJoint Venture Investment

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAdaptive BiotechnologiesFerring Pharmaceuticals
StartupHub scoreOur 0-100 rating69/10036/100
TractionNot published40/100
TeamNot published70/100
Search visibilityNot published16/100
QualityNot published30/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (25/100)
Domain ratingLink authority, 0-10062/10071/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAdaptive BiotechnologiesFerring Pharmaceuticals
HostingSelf ManagedAWS
CMSWordPressWordPress
FrameworksJqueryJquery, Bootstrap
AnalyticsGoogle Tag ManagerGoogle Analytics 4, Matomo, Linkedin Insight

What users say

MeasureAdaptive BiotechnologiesFerring Pharmaceuticals
Reddit sentimentThreads we trackNot published1 positive, 4 negative across 6 threads
Ferring Pharmaceuticals
$INVO today announced an amendment under its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals. The amendment provides for an increase in the number of INVO company-owned clinics initially allowable under the agreement
r/INVO

Adaptive Biotechnologies vs Ferring Pharmaceuticals: common questions

Which is better, Adaptive Biotechnologies or Ferring Pharmaceuticals?

On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Adaptive Biotechnologies and Ferring Pharmaceuticals compare on the numbers?

Adaptive Biotechnologies leads on our overall score (69/100 against 36/100), agent readiness (39/100 against 25/100). Ferring Pharmaceuticals leads on domain rating (71/100 against 62/100), funding raised ($570M against $300M).

What do real users say about Adaptive Biotechnologies and Ferring Pharmaceuticals?

Ferring Pharmaceuticals: 1 positive and 4 negative mentions across 6 Reddit threads we track, mostly in r/INVO.

Read the full Adaptive Biotechnologies review and pricing or the Ferring Pharmaceuticals review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.